Giulia Lori

Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma

Chiara Raggi, Maria Letizia Taddei, Elena Sacco et al. · Journal of Hepatology · 2021 · 157 citations · Full text

Cancer Metabolism, Mitochondrial Oxidative Metabolism, Mitochondrial Function +9

The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma

Margherita Correnti, A. Cappon, Mirella Pastore et al. · Liver International · 2021 · 62 citations · Full text

<i>PCSK9</i> rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD

Stefania Grimaudo, Stefano Bartesaghi, Raffaela Rametta et al. · Liver International · 2020 · 55 citations

An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications

Rosanna Maccari, Antonella Del Corso, Paolo Paoli et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 47 citations · Full text

Aldo-keto Reductase, Biochemistry, Medicine +8

Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents

Rosaria Ottanà, Paolo Paoli, Alexandra Naß et al. · European Journal of Medicinal Chemistry · 2016 · 40 citations · Full text

Medicinal Chemistry, Anti-inflammatory Agents, Biochemistry +11